Follow the Lincoln Pharmaceuticals Limited share price and the full management transaction log of the company, a listed equity based in India. Shares are listed on IN IN, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Lincoln Pharmaceuticals Limited has published 137 reports. Market capitalisation: €11bn. The latest transaction was disclosed on 6 June 2024 (Purchase). Among the most active insiders: Munjal Mahendrabhai Patel. The full history is openly available.
137
Insider Decl.
0
Thresholds
€15m
131 ops.
Buy Volume
€2m
6 ops.
Sell Volume
10Σ signal
Buys €15m€2m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 2,365 of 26,211 companies
74.7
score / 100
Value
70
Quality
79
FCF yld6.5%
Earn yld7.1%
EV/EBITDA9.4x
ROE12%
Gross mgn54%
Net mgn13%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.